H.C. Wainwright analyst Yi Chen downgraded Zynex (ZYXI) to Neutral from Buy without a price target The company reported a Q2 miss and an operational restructuring is in progress, the analyst tells investors in a research note. The firm says there is no visibility at this point as to when Tricare payments to Zynex will resume.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZYXI: